Drug intelligence / Profile preview

insect drug compound

Development stage: Unknown
Lead developer: Shanghai Municipal Hospital of Traditional Chinese Medicine
Modality: Small Molecules
Administration: Oral

Overview

Insect drug compound, also known as Insect Compound Particle (CYFF) or Chong Yao Fu Fang, is a Traditional Chinese Medicine (TCM) compound. It is formulated based on the principles of "invigorating spleen for strengthening vital qi" and "collateral disease theory." The primary components of this compound are Tianlong (gecko) and centipede. It is being investigated for its potential to reduce the toxicity associated with chemotherapy and enhance the anti-tumor effects in patients with colorectal cancer. Research suggests that its active components may exert tumor inhibitory effects and induce cell cycle arrest in cancer cells.

Other names: Insect Compound ParticleChong Yao Fu FangCYFF虫药复方模拟颗粒虫药复方颗粒

Beyond the preview

Go deeper on insect drug compound.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on insect drug compound.

Explore the full profile